ArticleParkinsonism & related disorders2026
Shortening the SWAL-QOL: Is it possible to create a valid short form?
Article in Parkinsonism & related disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeDysphagia is highly prevalent in movement disorders resulting in marked decrements to quality of life. The Swallowing-related Quality of Life Questionnaire (SWAL-QOL) provides critical information about the impact of dysphagia on quality of life (QOL) but is long and cumbersome. We examined whether the SWAL-QOL could be shortened, while maintaining the properties of the original scale.
methodsWe used a combinatoric approach to reduce the 30 items that inform the QOL domains to 10 items and the 14 items that inform the symptom-profile to five items in Parkinson's disease (PD). We tested the concurrent validity of the short-form in Progressive Supranuclear Palsy (PSP) and Cerebellar Ataxia (CA), and over time.
resultsOur sample included individuals with PD (n = 304), PSP (n = 33), and CA (n = 26) (age 65.7 [27-89]; 34% female). Correlations between the candidate short forms and the original QOL items ranged from 0.95 to 0.98 and for the symptom-profile from 0.91 to 0.95. Cronbach's alpha for the final 10-item short-form was 0.85 and for the 5-item symptom-profile was 0.74. Correlations between the short-form and original QOL domains were 0.98 in PSP and 0.98 in CA, and between the short and original symptom-profile were 0.98 in PSP and 0.96 in CA. Correlations between the short and original QOL items over time was 0.97 in PD, 0.99 in PSP, and 0.98 in CA and for the symptom-profile was 0.94 in PD, 0.95 in PSP, and 0.96 in CA.
conclusionsWe identified a 15-item SWAL-QOL with strong concurrent validity in movement disorder populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.